CapalJK, JesteSS. Autism and epilepsy. Pediatr Clin North Am, 2024; 71(2):241–252; doi: 10.1016/j.pcl.2024.01.004
2.
RogersJP, OldhamMA, FricchioneG, et al.Evidence-Based consensus guidelines for the management of catatonia: Recommendations from the British association for psychopharmacology. J Psychopharmacol, 2023; 37(4):327–369; doi: 10.1177/02698811231158232
3.
RogersJP, ShorvonS, LuccarelliJ. Catatonia and epilepsy: An underappreciated relationship. Epilepsy Behav, 2024; 159:109983; doi: 10.1016/j.yebeh.2024.109983
4.
SmithJR, LimS, BindraS, et al.Longitudinal symptom burden and pharmacologic management of catatonia in autism with intellectual disability: An observational study. Autism Res, 2025; 18(2):449–462; doi: 10.1002/aur.3315
5.
SmithJR, YorkT, HartS, et al.The development a pediatric catatonia clinical roadmap for clinical care at Vanderbilt University medical center. J Acad Consult-Liaison Psychiatry, 2024; 65(6):570–578; doi: 10.1016/j.jaclp.2024.08.003
6.
SrinivasanA, LuccarelliJ, TamargoR, et al.Treat to sedation: Managing intravenous placement for electroconvulsive therapy in autism with intellectual disability and hyperactive catatonia. J Child Adolesc Psychopharmacol, 2025; doi: 10.1089/cap.2025.0012